Roger Paredes obtained a degree and doctorate in Medicine and Surgery from the Autonomous University of Barcelona (UAB). His specialism in HIV resistance, at Brigham & Women's Hospital in Boston and Harvard Medical School, was funded by a post-doctoral scholarship from “la Caixa”. He has demonstrated the clinical utility of new methods of sequencing HIV in both high- and low-income countries. He is a member of the WHO HIV Drug Resistance Strategy (ResNet) Steering Committee and of the International Antiviral Society-USA, which publishes an international annual update of drug resistance mutations in HIV-1. He is co-author of the Rega algorithm for interpreting resistance to antiretrovirals and is a virologist for the EuroSIDA European cohort. His group has led pioneering research into the role of the gut microbiome in the pathogenesis of HIV infection and chronic inflammation. He combines his research with a medical care role in the HIV unit of the Germans Trias i Pujol University Hospital (Badalona).
Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients.
Vaccination with an HIV T-cell immunogen induces alterations in the mouse gut microbiota.
Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome.
Viral dynamics in patients with monkeypox infection: a prospective cohort study in Spain.